Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Array Technologies Inc ARRY

Industrials
Array Technologies, Inc. is a provider of utility-scale solar tracker technology. The Company manufactures ground-mounting tracking systems used in utility and distributed generation solar energy projects worldwide. The Company’s segments include Array Legacy Operations and STI Legacy Operations. Its principal products are a portfolio of integrated solar tracking systems comprised of software... see more

Recent & Breaking News (NDAQ:ARRY)

Array BioPharma Announces a 62% Observed Overall Survival at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO 20th World Congress on Gastrointestinal Cancer

PR Newswire June 23, 2018

Array BioPharma to Present Overall Survival Results from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant Colorectal Cancer at the ESMO 20th World Congress on Gastrointestinal Cancer

PR Newswire June 18, 2018

Array BioPharma Announces Additional Median Overall Survival Results of Encorafenib and Binimetinib in Patients with BRAF-mutant Advanced Melanoma

PR Newswire June 4, 2018

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates

Benzinga.com  June 1, 2018

Array BioPharma Announces Oral Presentation from the Pivotal Phase 3 COLUMBUS trial of the Combination of Encorafenib and Binimetinib in Patients with BRAF-mutant Melanoma at 2018 ASCO Annual Meeting

PR Newswire May 16, 2018

32 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  May 10, 2018

Array Biopharma To Present At The Bank Of America Merrill Lynch 2018 Health Care Conference

PR Newswire May 9, 2018

Array BioPharma Reports Financial Results For The Third Quarter of Fiscal 2018

PR Newswire May 9, 2018

Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway

Benzinga.com  May 9, 2018

Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2018 On May 9, 2018

PR Newswire April 30, 2018

Array BioPharma Announces Publication of Detailed Phase 3 COLUMBUS Trial Data of Encorafenib and Binimetinib in Melanoma Patients in The Lancet Oncology

PR Newswire March 22, 2018

Array BioPharma To Present At The Cowen 38th Annual Healthcare Conference

PR Newswire March 5, 2018

Array BioPharma To Present At The LEERINK Partners 7th Annual Global Healthcare Conference

PR Newswire February 7, 2018

40 Biggest Movers From Yesterday

Benzinga.com  February 7, 2018

Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2018

PR Newswire February 6, 2018

Encorafenib and Binimetinib Combination Treatment Demonstrates 33.6 Month Median Overall Survival (OS) in Patients with BRAF-Mutant Melanoma in Phase 3 COLUMBUS Trial

PR Newswire February 6, 2018

Array BioPharma Inc. to Host Earnings Call

Accesswire February 6, 2018

Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2018 On February 6, 2018

PR Newswire January 30, 2018

38 Biggest Movers From Yesterday

Benzinga.com  January 23, 2018

32 Stocks Moving In Monday's Mid-Day Session

Benzinga.com  January 22, 2018